Daniel Ermann

6PUBLICATIONS

19CO-AUTHORS

Cancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursCardiology (incl. cardiovascular diseases)Predictive and prognostic markers

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (6)

Sort by Publication Date:

|Jun 30, 2026

Real-world comparative effectiveness of first-line BTK inhibitors in chronic lymphocytic leukemia.

|Jun 24, 2026

Hypertension and time to treatment failure with acalabrutinib and ibrutinib in treatment-naïve CLL/SLL.

|Jan 19, 2024

T-cell prolymphocytic leukemia: Epidemiology and survival trends in the era of novel treatments.

Victoria A Vardell, Daniel A Ermann, Lindsey Fitzgerald

|Apr 20, 2023

Influence of racial and ethnic identity on overall survival in patients with chronic lymphocytic leukemia.

Victoria A Vardell, Daniel A Ermann, Lindsey A Fitzgerald

|Oct 21, 2022

Impact of academic medical center access on outcomes in multiple myeloma.

Victoria A Vardell, Daniel A Ermann, Srinivas K Tantravahi

|Sep 02, 2022

Frontline polatuzumab vedotin for diffuse large B-cell lymphoma: A survey of clinician impressions.

Ajay Major, Edward R Scheffer Cliff, Daniel A Ermann

Pageof 1

Frequent Collaborators

Victoria A Vardell

Harsh Shah

Boyu Hu

Ajay Major

Edward R Scheffer Cliff

1 joint publications

David A Russler-Germain

1 joint publications

Srinivas K Tantravahi

1 joint publications

Brian McClune

1 joint publications

Amandeep Godara

1 joint publications

Ghulam Rehman Mohyuddin

Frequent Collaborators

Victoria A Vardell

Harsh Shah

Boyu Hu

Ajay Major